VenoStent
Latest round
- Series A
Last raised
- Jun 2024
Total raised
- $23M
Investors
- 13
About VenoStent
Founded in 2017 and based in Texas, US, VenoStent, Inc. operates as a developer of medical devices for patients with hemodialysis. The firm was founded by CEO Tim Boire and COO Geoffrey Lucks. In July 2023, VenoStent, Inc.vc, and Texas Medical Center Ventures. VenoStent, Inc. provides SelfWrap, a polymer engineering technology that eliminates vascular surgery failures for hemodialysis treatment.
Who invested in VenoStent
13 investors across 5 rounds
See all investors in VenoStent
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about VenoStent
Who invested in VenoStent?
VenoStent has 13 investors on record across 5 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has VenoStent raised?
VenoStent has raised 5 venture rounds. Sign up free to see how much each round raised and the total.
When did VenoStent last raise money?
VenoStent's most recent round on record is a Series A, in Jun 2024.
What does VenoStent do?
Founded in 2017 and based in Texas, US, VenoStent, Inc.
Where is VenoStent headquartered?
VenoStent is headquartered in Houston, US.
Which VCs invest in companies like VenoStent?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back medical devices & equipment companies at VenoStent's stage. Their profiles are linked below.
VCs backing medical devices & equipment startups at Series A
Raising like VenoStent? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.